Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
2011 Jul;31(7):735-43
The impact of glucose-lowering drugs on sarcopenia in type 2 diabetes: current evidence and underlying mechanisms
In 2025, Catalyst supported projects spanning AI-designed proteins (Profluent), precision trait discovery (Phytoform Labs), biocontrol peptides (Micropep), and soil bioenhancers (Puna Bio), signalling a push to externalise discovery while scaling internally
It is designed to be used alongside healthy eating habits and lifestyle changes, rather than as a standalone solution
US$ 21.84
US$ 23.20
US$ 21.22
US$ 27.62
US$ 28.75
